TY - JOUR
KW - Animals
KW - Area Under Curve
KW - Bioavailability
KW - Biological Availability
KW - Calibration
KW - Chromatography, High Pressure Liquid/instrumentation/methods/standards
KW - Drug Stability
KW - Eluxadoline
KW - Gastrointestinal Agents/administration & dosage/blood/chemistry/pharmacokinetics
KW - Imidazoles/administration & dosage/blood/chemistry/pharmacokinetics
KW - Lactic Acid/chemistry
KW - Limit of Detection
KW - mu-SPE
KW - Nanoparticles/chemistry
KW - Phenylalanine/administration & dosage/analogs & derivatives/blood/chemistry/pharmacokinetics
KW - Polyglycolic Acid/chemistry
KW - Polymethacrylic Acids/chemistry
KW - Rats
KW - Receptors, Opioid, delta/antagonists & inhibitors
KW - Receptors, Opioid, kappa/agonists
KW - Receptors, Opioid, mu/agonists
KW - Reference Standards
KW - Reproducibility of Results
KW - Risperidone/analysis
KW - Sensitivity and Specificity
KW - Solid Phase Microextraction/instrumentation/methods/standards
KW - Substance Abuse Detection/instrumentation/methods/standards
KW - SWGTOX
KW - Tandem Mass Spectrometry/instrumentation/methods/standards
KW - UPLC-MS/MS
AU - M. Iqbal
AU - E. Ezzeldin
AU - K. A. Al-Rashood
AU - R. Al-Shdefat
AU - M. K. Anwer
A1 - 
BT - Journal of pharmaceutical and biomedical analysis
C5 - Opioids & Substance Use
CY - England
JF - Journal of pharmaceutical and biomedical analysis
PB - Elsevier B.V
PP - England
PY - 2018
SN - 1873-264X; 0731-7085
SP - 172
EP - 178
EP - 
T1 - High throughput mu-SPE based elution coupled with UPLC-MS/MS for determination of eluxadoline in plasma sample: Application in pharmacokinetic characterization of PLGA nanoparticle formulations in rats
T2 - Journal of pharmaceutical and biomedical analysis
TI - High throughput mu-SPE based elution coupled with UPLC-MS/MS for determination of eluxadoline in plasma sample: Application in pharmacokinetic characterization of PLGA nanoparticle formulations in rats
U1 - Opioids & Substance Use
U2 - 29121571
VL - 149
VO - 1873-264X; 0731-7085
Y1 - 2018
ER -